NuGene International Inc (OTCBB:NUGN) continues to trade moderate volume in the mid $0.60 range in recent weeks. NUGN was a hard mailer promotion featuring Kathy Ireland and the headline ”Did Kathy Ireland just discover Botox without the needle? hit the bb’s. In its heyday NUGN surged to an incredible $4.55 a share.
NUGN started trading on the OTC in February of last year, going public via a reverse merger with Bling Marketing, Inc. who had tried their hand at ”becoming a wholesaler of jewelry, principally earrings, rings and pendants.” along with the name change to NuGene International Inc the new Company affected a 15.04 for 1 forward stock split.
NuGene International Inc (OTCBB:NUGN) bills itself as a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media.
According to NUGN the US Department of Health and Human Services calls regenerative medicine the “next evolution of medical treatments.” The regenerative medical market, which includes cosmeceuticals and pharmaceuticals, was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report.
NuGene’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has two patents pending covering 15 unique applications and inventions. NuGene’s goal is to leverage its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.
To Find out the inside Scoop on NUGN Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In October NUGN announced it has filed additional provisional patents to extend the intellectual property around its proprietary stem cell formulations. The Company has filed two provisional patent applications in the U.S. Patent and Trademark Office for inventions relating to electro-active dressings and bandages. These include inventions combining electro-active sterile dressings and NuGene’s proprietary human adipose derived stem cell culture media.
According to the disclaimer for the NUGN promotion ”Casson Media Group, Inc. (CMG), an affiliated company of MicroCap MarketPlace has received nine thousand dollars in cash compensation from Result Corporation, a third party shareholder of NUGN to assist in the writing of this Advertisement, and anticipates receiving potential future subscription and advertising revenues, the amount of which is not known and cannot be predicted at this time. Result Corporation, besides compensating CMG, paid two million two hundred and eighty thousand dollars to marketing vendors to cover all the costs of creating and distributing this Advertisement, including printing and postage, in an effort to build investor and market awareness.
On July 27 NUGN announced it has appointed Steve Carlson as CEO and President. NuGene Co-Founder Ali Kharazmi said, “Steve has a history of building world class organizations by bringing people together who can rapidly and creatively commercialize new technologies. This is a huge win for NuGene. We are excited to have him take the lead role with our unique stem cell technology.”
Mr. Carlson began his career at Allergan. During his 15 year tenure he rose to the position of Senior Vice President of Marketing, where he lead the licensing, development and early commercialization of one of the worlds most recognized brands – Botox(R). Mr. Carlson subsequently served as CEO, President and Director of Obagi Medical Products, a global pharmaceutical skin care line where he successfully led the company’s public offering in 2006.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $26 million market valuation NUGN does have $1.3 million in the treasury and growing revenues reporting $723,438 in sales in 2014. But the stock was subject to a massive $2.28 million 28-page glossy hard mailer promotion featuring Kathy Ireland causing the stock to be a staple among volume leaders in multi-dollar land for months. The shares being liquidated into this promotion are likely the 11.1 million free trading shares converted at just $0.0033 split adjusted according to filings. Short term NUGN could move higher, long term the stock has no real fundamentals to back up anywhere near current valuation and could drop big once the promo dollars run dry. We will be updating on NUGN when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NUGN.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in NUGN either long or short and we have not been compensated for this article.